Chapter 1. ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET– Scope & Methodology

1.1. Market Segmentation

1.2. Assumptions

1.3. Research Methodology

1.4. Primary Sources

1.5. Secondary Sources

Chapter 2. ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET– Executive Summary

2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)

2.2. Key Trends & Insights

2.3. COVID-121 Impact Analysis

      2.3.1. Impact during 2023 – 2030

      2.3.2. Impact on Supply – Demand

Chapter 3. ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET– Competition Scenario

3.1. Market Share Analysis

3.2. Product Benchmarking

3.3. Competitive Strategy & Development Scenario

3.4. Competitive Pricing Analysis

3.5. Supplier - Distributor Analysis

Chapter 4. ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET- Entry Scenario

4.1. Case Studies – Start-up/Thriving Companies

4.2. Regulatory Scenario - By Region

4.3 Customer Analysis

4.4. Porter's Five Force Model

       4.4.1. Bargaining Power of Suppliers

       4.4.2. Bargaining Powers of Customers

       4.4.3. Threat of New Entrants

       4.4.4. Rivalry among Existing Players

       4.4.5. Threat of Substitutes

Chapter 5. ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET- Landscape

5.1. Value Chain Analysis – Key Stakeholders Impact Analysis

5.2. Market Drivers

5.3. Market Restraints/Challenges

5.4. Market Opportunities

Chapter 6. ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET– By Type

6.1. Synthetic APIs

6.2. Biotech APIs

Chapter 7. ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET– By Type of Synthesis

7.1. In-house

7.2. Contract

Chapter 8. ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET– By Type of Manufacturer

8.1. Captive

8.2. Merchant

Chapter 9. ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET– By Type of Drug

9.1. Branded

9.2. Generic

Chapter 10. ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET– By Therapeutic Area

10.1. Cardiovascular and Hematopoietic System

10.2. CNS and Neurological Disorders

10.3. Endocrinology

10.4. Oncology

10.5. Musculoskeletal

10.6. Respiratory

10.7. Gastrointestinal

10.8. Other Therapeutic Applications

Chapter 11. ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET– By Region

11.1. North America

11.2. Europe

11.3. The Asia Pacific

11.4. Latin America

11.5. Middle-East and Africa

Chapter 12. ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET – Company Profiles – (Overview, Product Portfolio, Financials, Developments)

12.1. Company 1

12.2. Company 2

12.3. Company 3

12.4. Company 4

12.5. Company 5

12.6. Company 6

12.7. Company 7

12.8. Company 8

12.9. Company 9

12.10. Company 10